Lilly’s Baqsimi is a needle-free, simple treatment for severe hypoglycemia – bringing long-needed innovation to use of glucagon in emergency settings. Expected in...
Complications
Staying healthy when you have diabetes is possible with careful blood glucose management – that’s the best way to reduce your risk of long-term health complications.
Higher blood sugar levels cause damage over time to blood vessels and nerves, which can affect your eyes, heart, kidneys, and other organs. It’s important to be aware of these diabetes-related health complications so that you can act now to avoid them or prevent them from progressing.
- Heart and blood vessel problems
- Infographic: diabetes and heart disease
- Nerve damage (neuropathy)
- Infographic: neuropathy
- Kidney damage (nephropathy)
- Infographic: diabetes and kidney disease
- Eye damage
- Diabetic ketoacidosis (DKA)
- Foot damage and amputation
- Depression or diabetes distress
- Pregnancy complications
- Gastroparesis
22 readers recommended
42 readers recommended
While ketosis and ketoacidosis sound quite similar – and both describe elevated ketones in the blood – there are critical differences
10 readers recommended
Are people aware of the link between diabetes and heart health? Do they know that certain diabetes drugs may protect the heart? Is heart health commonly discussed with...
16 readers recommended
How one clinic is integrating diabetes and heart health, focusing on comprehensive risk reduction, including medications that both lower blood glucose and protect the...
27 readers recommended
A recent study found 38% of those with type 1 diagnosed after age 30 were not initially given insulin; learn ways of differentiating between type 1 and type 2 at...
12 readers recommended
Eylea can help reduce the risk of vision loss, a common complication of diabetes
15 readers recommended
Results from the CREDENCE trial suggest that Invokana’s kidney benefits exist on top of blood pressure lowering medications (standard of care)
19 readers recommended
New study results from the PIONEER 6 trial show that once-daily pill semaglutide does not increase the risk of heart-related death, heart attack, and stroke
13 readers recommended
New guidelines by the US Department of Health and Human Services emphasize the benefit of ANY increased physical activity
21 readers recommended
FDA updates Invokana label – the type 2 diabetes therapy now improves heart health in type 2’s with established heart disease in addition to glucose lowering
15 readers recommended
Foot and hand cream, moisturizing cream, and cleansing wash now available at Walgreens, Target, and Amazon.com
15 readers recommended
Recently announced results from the REWIND and EMPRISE studies show heart protective effects of GLP1-agonist Trulicity and SGLT-2 inhibitor Jardiance in people with and...
27 readers recommended
Heart benefits of the SGLT-2 inhibitor pill beyond blood sugars and weight loss for people with type 2 diabetes
15 readers recommended
A new study will investigate whether SGLT-2 inhibitor Farxiga can delay the progression of heart failure in people with and without type 2 diabetes
28 readers recommended
A study recruiting 10,000 people will look at whether Zynquista (sotagliflozin) has effects beyond glucose-lowering and weight loss
18 readers recommended
The results were so positive it was deemed unethical to keep giving people placebo instead of Invokana, an SGLT-2 inhibitor approved for type 2 diabetes
14 readers recommended
Simple steps you can take to reduce your risk for heart failure. Plus, how to work with your health professional to manage it once you’ve been diagnosed.
44 readers recommended
Learn what heart failure is, what it has to do with diabetes, and how to identify and talk about this complication that’s often less discussed.
20 readers recommended
Two new studies will investigate whether SGLT-2 inhibitor Jardiance impacts heart failure in people with and without diabetes. Jardiance is already approved to lower A1C...
19 readers recommended
Two new studies will investigate whether SGLT-2 inhibitor Farxiga impacts heart failure in people with type 2 diabetes and prediabetes